دورية أكاديمية

Mutations in a guanylate cyclase GCY-35/GCY-36 modify Bardet-Biedl syndrome-associated phenotypes in Caenorhabditis elegans.

التفاصيل البيبلوغرافية
العنوان: Mutations in a guanylate cyclase GCY-35/GCY-36 modify Bardet-Biedl syndrome-associated phenotypes in Caenorhabditis elegans.
المؤلفون: Mok CA; The Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada., Healey MP, Shekhar T, Leroux MR, Héon E, Zhen M
المصدر: PLoS genetics [PLoS Genet] 2011 Oct; Vol. 7 (10), pp. e1002335. Date of Electronic Publication: 2011 Oct 13.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101239074 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1553-7404 (Electronic) Linking ISSN: 15537390 NLM ISO Abbreviation: PLoS Genet Subsets: MEDLINE
أسماء مطبوعة: Original Publication: San Francisco, CA : Public Library of Science, c2005-
مواضيع طبية MeSH: Bardet-Biedl Syndrome/*genetics , Caenorhabditis elegans/*genetics , Caenorhabditis elegans Proteins/*genetics , Cyclic GMP-Dependent Protein Kinases/*genetics , Guanylate Cyclase/*genetics , Nerve Tissue Proteins/*genetics, Animals ; Animals, Genetically Modified ; Bardet-Biedl Syndrome/metabolism ; Body Size/genetics ; Caenorhabditis elegans Proteins/metabolism ; Cilia/genetics ; Cilia/metabolism ; Cyclic GMP/genetics ; Cyclic GMP/metabolism ; Cyclic GMP-Dependent Protein Kinases/metabolism ; Disease Models, Animal ; Guanylate Cyclase/metabolism ; Humans ; Mutation ; Nerve Tissue Proteins/metabolism ; Phenotype ; Protein Transport/genetics ; Sensory Receptor Cells/metabolism ; Signal Transduction/genetics
مستخلص: Ciliopathies are pleiotropic and genetically heterogeneous disorders caused by defective development and function of the primary cilium. Bardet-Biedl syndrome (BBS) proteins localize to the base of cilia and undergo intraflagellar transport, and the loss of their functions leads to a multisystemic ciliopathy. Here we report the identification of mutations in guanylate cyclases (GCYs) as modifiers of Caenorhabditis elegans bbs endophenotypes. The loss of GCY-35 or GCY-36 results in suppression of the small body size, developmental delay, and exploration defects exhibited by multiple bbs mutants. Moreover, an effector of cGMP signalling, a cGMP-dependent protein kinase, EGL-4, also modifies bbs mutant defects. We propose that a misregulation of cGMP signalling, which underlies developmental and some behavioural defects of C. elegans bbs mutants, may also contribute to some BBS features in other organisms.
Competing Interests: The authors have declared that no competing interests exist.
References: Nat Genet. 2010 Oct;42(10):840-50. (PMID: 20835237)
Cell. 1998 Sep 4;94(5):679-89. (PMID: 9741632)
Nat Genet. 2004 Sep;36(9):994-8. (PMID: 15322545)
Hum Mol Genet. 2006 Mar 1;15(5):667-77. (PMID: 16399798)
Nature. 2003 Nov 6;426(6962):83-7. (PMID: 14603322)
Neuron. 2009 Mar 26;61(6):865-79. (PMID: 19323996)
Genetics. 2006 May;173(1):131-49. (PMID: 16547101)
Nature. 2005 Jul 28;436(7050):583-7. (PMID: 16049494)
Mol Biol Cell. 2008 Apr;19(4):1540-7. (PMID: 18256283)
Development. 2011 Mar;138(6):1183-93. (PMID: 21343369)
Nat Genet. 2005 Oct;37(10):1135-40. (PMID: 16170314)
Nature. 2004 Jul 15;430(6997):317-22. (PMID: 15220933)
Nat Cell Biol. 2008 Jan;10(1):70-6. (PMID: 18084282)
PLoS Biol. 2006 Sep;4(9):e274. (PMID: 16903785)
Hum Genet. 2006 Sep;120(2):211-26. (PMID: 16794820)
Pharmacol Rev. 2000 Sep;52(3):375-414. (PMID: 10977868)
Science. 2010 Sep 10;329(5997):1337-40. (PMID: 20671153)
J Cell Biol. 2006 Sep 25;174(7):1035-45. (PMID: 17000880)
Hum Mol Genet. 2011 Apr 15;20(8):1625-32. (PMID: 21282186)
Curr Biol. 2009 Jul 14;19(13):R526-35. (PMID: 19602418)
Cell. 2010 Jun 25;141(7):1208-19. (PMID: 20603001)
Annu Rev Genomics Hum Genet. 2006;7:125-48. (PMID: 16722803)
Genetics. 2006 May;173(1):177-87. (PMID: 16547093)
Cell. 2007 Jun 15;129(6):1201-13. (PMID: 17574030)
Curr Biol. 2004 Jun 22;14(12):1105-11. (PMID: 15203005)
Curr Biol. 2005 Oct 25;15(20):1861-6. (PMID: 16243034)
Genes Dev. 2004 Jul 1;18(13):1630-42. (PMID: 15231740)
EMBO J. 2002 Mar 1;21(5):1063-73. (PMID: 11867534)
Am J Med Genet C Semin Med Genet. 2009 Nov 15;151C(4):281-95. (PMID: 19876933)
J Med Genet. 1997 Feb;34(2):92-8. (PMID: 9039982)
Nat Genet. 2008 Jan;40(1):69-77. (PMID: 18066062)
Front Biosci. 2005 May 01;10:1279-89. (PMID: 15769624)
Rev Physiol Biochem Pharmacol. 1999;135:41-65. (PMID: 9932480)
Neuron. 2002 Dec 19;36(6):1079-89. (PMID: 12495623)
Genome Biol. 2005;6(2):R17. (PMID: 15693946)
Genes Cells. 2004 Jan;9(1):39-47. (PMID: 14723706)
Mol Cell. 2000 Mar;5(3):411-21. (PMID: 10882127)
Cell Metab. 2008 Mar;7(3):249-57. (PMID: 18316030)
J Neurochem. 2009 Feb;108(3):796-810. (PMID: 19187097)
PLoS Genet. 2010 Mar 19;6(3):e1000884. (PMID: 20333246)
Proc Natl Acad Sci U S A. 2004 Nov 23;101(47):16588-93. (PMID: 15539463)
Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17524-9. (PMID: 17959775)
J Clin Invest. 2009 Mar;119(3):428-37. (PMID: 19252258)
Am J Med Genet. 1995 Nov 6;59(2):199-203. (PMID: 8588586)
Nature. 2002 Oct 31;419(6910):925-9. (PMID: 12410311)
Nature. 2006 Jan 19;439(7074):326-30. (PMID: 16327777)
Hum Mol Genet. 2008 Jul 1;17(13):1956-67. (PMID: 18381349)
Br Med Bull. 1973 Sep;29(3):269-71. (PMID: 4807330)
Nature. 2003 Oct 9;425(6958):628-33. (PMID: 14520415)
Genet Med. 2009 Jun;11(6):386-402. (PMID: 19421068)
Cell Metab. 2008 Apr;7(4):291-301. (PMID: 18396135)
Genes Dev. 2001 Mar 15;15(6):672-86. (PMID: 11274053)
Science. 2007 Jul 20;317(5836):372-6. (PMID: 17641202)
Nature. 2005 Oct 13;437(7061):1018-21. (PMID: 16136078)
Genetics. 2006 Apr;172(4):2239-52. (PMID: 16415369)
WormBook. 2007 Mar 08;:1-22. (PMID: 18050505)
Nat Neurosci. 2011 Jun 05;14(7):911-8. (PMID: 21642975)
Mol Biol Cell. 2007 May;18(5):1554-69. (PMID: 17314406)
Nat Neurosci. 2003 Nov;6(11):1178-85. (PMID: 14555955)
Physiol Rev. 2006 Jan;86(1):1-23. (PMID: 16371594)
J Med Genet. 2010 Jul;47(7):453-63. (PMID: 20472660)
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5286-91. (PMID: 12672950)
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1820-5. (PMID: 19190184)
Hum Mol Genet. 2009 Apr 1;18(7):1323-31. (PMID: 19150989)
Science. 1996 Dec 20;274(5295):2082-6. (PMID: 8953039)
Trends Genet. 2000 Jan;16(1):27-33. (PMID: 10637628)
Neuron. 2002 Dec 19;36(6):1091-102. (PMID: 12495624)
Curr Biol. 2007 Jan 23;17(2):159-64. (PMID: 17240342)
Development. 2003 Mar;130(6):1089-99. (PMID: 12571101)
Curr Biol. 2005 May 24;15(10):905-17. (PMID: 15916947)
معلومات مُعتمدة: MOP-93619 Canada Canadian Institutes of Health Research; MOP-97956 Canada Canadian Institutes of Health Research
المشرفين على المادة: 0 (Caenorhabditis elegans Proteins)
0 (Nerve Tissue Proteins)
0 (osm-12 protein, C elegans)
EC 2.7.11.12 (Cyclic GMP-Dependent Protein Kinases)
EC 2.7.11.12 (EGL-4 protein, C elegans)
EC 4.6.1.2 (GCY-35 protein, C elegans)
EC 4.6.1.2 (GCY-36 protein, C elegans)
EC 4.6.1.2 (Guanylate Cyclase)
H2D2X058MU (Cyclic GMP)
تواريخ الأحداث: Date Created: 20111025 Date Completed: 20120210 Latest Revision: 20211020
رمز التحديث: 20240829
مُعرف محوري في PubMed: PMC3192831
DOI: 10.1371/journal.pgen.1002335
PMID: 22022287
قاعدة البيانات: MEDLINE
الوصف
تدمد:1553-7404
DOI:10.1371/journal.pgen.1002335